In my views, we and Jon should not pay attention to short-mid term stock price, no need for buyback and deplete reserve and focus on taking the right call with NNZ-2591.
Next three months should change the sentiment, FDA meet, hopefully Daybue sale match or exceed analysts in Nov with positive outlook for next quarter and Canada approval progresses well, if it is just manipulation not much time left for market makers to do so.
cherry on top would be the next indications for NNZ.
Share Price, page-11654
-
- There are more pages in this discussion • 1,389 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.47 |
Change
-0.100(0.60%) |
Mkt cap ! $2.116B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $16.62 | $15.60 | $8.250M | 506.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 194 | $16.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.47 | 433 | 8 |
View Market Depth
| Last trade - 14.53pm 11/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |